Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cresco Labs (CRLBF) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for Cresco Labs (CRLBF) over the last 6 years, with Q3 2025 value amounting to $85.6 million.

  • Cresco Labs' Cost of Revenue fell 91.73% to $85.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $344.9 million, marking a year-over-year decrease of 421.19%. This contributed to the annual value of $359.9 million for FY2024, which is 1190.4% down from last year.
  • Cresco Labs' Cost of Revenue amounted to $85.6 million in Q3 2025, which was down 91.73% from $80.4 million recorded in Q2 2025.
  • Over the past 5 years, Cresco Labs' Cost of Revenue peaked at $111.9 million during Q4 2022, and registered a low of $80.4 million during Q2 2025.
  • For the 5-year period, Cresco Labs' Cost of Revenue averaged around $98.9 million, with its median value being $101.2 million (2022).
  • As far as peak fluctuations go, Cresco Labs' Cost of Revenue soared by 7447.69% in 2021, and later plummeted by 1943.48% in 2024.
  • Over the past 5 years, Cresco Labs' Cost of Revenue (Quarter) stood at $107.8 million in 2021, then grew by 3.81% to $111.9 million in 2022, then fell by 17.68% to $92.1 million in 2023, then fell by 0.23% to $91.9 million in 2024, then decreased by 6.89% to $85.6 million in 2025.
  • Its Cost of Revenue stands at $85.6 million for Q3 2025, versus $80.4 million for Q2 2025 and $87.1 million for Q1 2025.